Cargando…

GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC

BACKGROUND: Mesenchymal stromal cells (MSC) have gained importance in tissue repair, tissue engineering and in immunosupressive therapy during the last years. Due to the limited availability of MSC in the bone marrow, ex vivo amplification prior to clinical application is requisite to obtain therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Fekete, Natalie, Rojewski, Markus T., Fürst, Daniel, Kreja, Ludwika, Ignatius, Anita, Dausend, Julia, Schrezenmeier, Hubert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419200/
https://www.ncbi.nlm.nih.gov/pubmed/22905242
http://dx.doi.org/10.1371/journal.pone.0043255
_version_ 1782240701716627456
author Fekete, Natalie
Rojewski, Markus T.
Fürst, Daniel
Kreja, Ludwika
Ignatius, Anita
Dausend, Julia
Schrezenmeier, Hubert
author_facet Fekete, Natalie
Rojewski, Markus T.
Fürst, Daniel
Kreja, Ludwika
Ignatius, Anita
Dausend, Julia
Schrezenmeier, Hubert
author_sort Fekete, Natalie
collection PubMed
description BACKGROUND: Mesenchymal stromal cells (MSC) have gained importance in tissue repair, tissue engineering and in immunosupressive therapy during the last years. Due to the limited availability of MSC in the bone marrow, ex vivo amplification prior to clinical application is requisite to obtain therapeutic applicable cell doses. Translation of preclinical into clinical-grade large-scale MSC expansion necessitates precise definition and standardization of all procedural parameters including cell seeding density, culture medium and cultivation devices. While xenogeneic additives such as fetal calf serum are still widely used for cell culture, its use in the clinical context is associated with many risks, such as prion and viral transmission or adverse immunological reactions against xenogeneic components. METHODS AND FINDINGS: We established animal-free expansion protocols using platelet lysate as medium supplement and thereby could confirm its safety and feasibility for large-scale MSC isolation and expansion. Five different GMP-compliant standardized protocols designed for the safe, reliable, efficient and economical isolation and expansion of MSC was performed and MSC obtained were analyzed for differentiation capacity by qPCR and histochemistry. Expression of standard MSC markers as defined by the International Society for Cellular Therapy as well as expression of additional MSC markers and of various chemokine and cytokine receptors was analysed by flow cytometry. Changes of metabolic markers and cytokines in the medium were addressed using the LUMINEX platform. CONCLUSIONS: The five different systems for isolation and expansion of MSC described in this study are all suitable to produce at least 100 millions of MSC, which is commonly regarded as a single clinical dose. Final products are equal according to the minimal criteria for MSC defined by the ISCT. We showed that chemokine and integrin receptors analyzed had the same expression pattern, suggesting that MSC from either of the systems show equal characteristics of homing and adhesion.
format Online
Article
Text
id pubmed-3419200
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34192002012-08-19 GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC Fekete, Natalie Rojewski, Markus T. Fürst, Daniel Kreja, Ludwika Ignatius, Anita Dausend, Julia Schrezenmeier, Hubert PLoS One Research Article BACKGROUND: Mesenchymal stromal cells (MSC) have gained importance in tissue repair, tissue engineering and in immunosupressive therapy during the last years. Due to the limited availability of MSC in the bone marrow, ex vivo amplification prior to clinical application is requisite to obtain therapeutic applicable cell doses. Translation of preclinical into clinical-grade large-scale MSC expansion necessitates precise definition and standardization of all procedural parameters including cell seeding density, culture medium and cultivation devices. While xenogeneic additives such as fetal calf serum are still widely used for cell culture, its use in the clinical context is associated with many risks, such as prion and viral transmission or adverse immunological reactions against xenogeneic components. METHODS AND FINDINGS: We established animal-free expansion protocols using platelet lysate as medium supplement and thereby could confirm its safety and feasibility for large-scale MSC isolation and expansion. Five different GMP-compliant standardized protocols designed for the safe, reliable, efficient and economical isolation and expansion of MSC was performed and MSC obtained were analyzed for differentiation capacity by qPCR and histochemistry. Expression of standard MSC markers as defined by the International Society for Cellular Therapy as well as expression of additional MSC markers and of various chemokine and cytokine receptors was analysed by flow cytometry. Changes of metabolic markers and cytokines in the medium were addressed using the LUMINEX platform. CONCLUSIONS: The five different systems for isolation and expansion of MSC described in this study are all suitable to produce at least 100 millions of MSC, which is commonly regarded as a single clinical dose. Final products are equal according to the minimal criteria for MSC defined by the ISCT. We showed that chemokine and integrin receptors analyzed had the same expression pattern, suggesting that MSC from either of the systems show equal characteristics of homing and adhesion. Public Library of Science 2012-08-14 /pmc/articles/PMC3419200/ /pubmed/22905242 http://dx.doi.org/10.1371/journal.pone.0043255 Text en © 2012 Fekete et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Fekete, Natalie
Rojewski, Markus T.
Fürst, Daniel
Kreja, Ludwika
Ignatius, Anita
Dausend, Julia
Schrezenmeier, Hubert
GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC
title GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC
title_full GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC
title_fullStr GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC
title_full_unstemmed GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC
title_short GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC
title_sort gmp-compliant isolation and large-scale expansion of bone marrow-derived msc
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419200/
https://www.ncbi.nlm.nih.gov/pubmed/22905242
http://dx.doi.org/10.1371/journal.pone.0043255
work_keys_str_mv AT feketenatalie gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc
AT rojewskimarkust gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc
AT furstdaniel gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc
AT krejaludwika gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc
AT ignatiusanita gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc
AT dausendjulia gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc
AT schrezenmeierhubert gmpcompliantisolationandlargescaleexpansionofbonemarrowderivedmsc